ClinicalTrials.govpublic full text
Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B
chronic hepatitis b, hep b, non cirrhotic, tenofovir disoproxil fumarate (tdf), peginterferon α-2a (peg-ifn), interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 810452
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.